Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3048 results

Sort By:

Extended Ablation Versus Pulmonary Vein Isolation to Treat Persistent Atrial Fibrillation

Study ID: NCT07424326
Start Date: 2026-06-01
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

450

Intervention / Treatment

PVI-plus

PVI-only

Sponsor

Charles University, Czech Republic

Source: clinicaltrials.gov

Share:
Add to list

"Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis"

Study ID: NCT07210008
Start Date: 2026-06-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

120

Intervention / Treatment

Prednisolone

Placebo

Sponsor

Public Assistance - Paris Hospitals

Source: clinicaltrials.gov

Share:
Add to list

Silicon-based Photon Counting Computed Tomography for Advanced Cardiac Imaging

Study ID: NCT07411196
Start Date: 2026-08-01
End Date: 2029-01-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Photon-counting computed tomography

Sponsor

Ronny R Buechel, MD

Source: clinicaltrials.gov

Share:
Add to list

Knee Arthroplasty Recovery With Transcranial Direct Current Stimulation

Study ID: NCT07351578
Start Date: 2026-05
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

Active tDCS Stimulation

Sham tDCS Stimulation

Sponsor

Women's College Hospital

Source: clinicaltrials.gov

Share:
Add to list

Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction

Study ID: NCT07214948
Start Date: 2026-03-15
End Date: 2026-10-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

NO Catheters

Currently used single balloon catheter

Sponsor

Aalto University

Source: clinicaltrials.gov

Share:
Add to list

Multicenter Study of Transcranial Magnetic Stimulation on Vision Restoration

Study ID: NCT07425717
Start Date: 2026-06-01
End Date: 2029-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

136

Intervention / Treatment

Transcranial magnetic stimulation targeting occipital visual cortex

Sham stimulation

Sponsor

Shanghai High Myopia Study Group

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus

Study ID: NCT07381465
Start Date: 2026-04-15
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

15

Intervention / Treatment

Forty-sekibart

Sponsor

Chinese SLE Treatment And Research Group

Source: clinicaltrials.gov

Share:
Add to list

B4P Trial - BLOOM43 for Preconditioning

Study ID: NCT07340632
Start Date: 2026-03-16
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

BLOOM43

Sponsor

Plexaa Ltd

Source: clinicaltrials.gov

Share:
Add to list

SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

Study ID: NCT03867487
Start Date: 2027-05-01
End Date: 2028-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Empagliflozin 10 MG

Placebo Oral Tablet

Sponsor

Justin Ryder

Source: clinicaltrials.gov

Share:
Add to list

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

Study ID: NCT07012031
Start Date: 2026-08-07
End Date: 2027-06-14
Study Type

Interventional

Study Phase

Phase2

No. of Participants

37

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Echocardiography Test

Magnetic Resonance Imaging

Multigated Acquisition Scan

Sotorasib

Trastuzumab Deruxtecan

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list